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Gene-Gene Interaction Testing Framework, by
Millstein et al. (p. 15)
As the search for gene variations that are associated with
disease becomes more commonplace, the development
of methods to identify genes that interact to cause an
effect is crucial. Looking at the effects of single genes
alone can be complicated by genetic heterogeneity or by
the fact that the single effects simply are not large enough
to be observed. Millstein et al. propose a new testing
strategy that efﬁciently determines epistatic interactions
of genes, both in the presence and in the absence of main
effects. With simulations, this method—the focused in-
teraction testing framework (FITF)—outperforms mar-
ginal tests and the multifactor dimensionality reduction
(MDR) when dealing with additive, dominant, or re-
cessive gene interactions. The usefulness of the strategy
is demonstrated through analysis of an asthma cohort
from the Children’s Health Study. From a case-control
comparison of polymorphisms in 12 candidate genes
from pathways involving oxidative stress and inﬂam-
mation, the marginal method identiﬁed a protective
effect for a rare allele of NQO1. But, only FITF was
able to signiﬁcantly establish an association between
asthma and a gene set consisting of NQO1, MPO, and
CAT. Importantly, this association was also replicated
in a new group of asthma patients from other ethnic
backgrounds.
Human LUNATIC FRINGE Mutation, by Sparrow et
al. (p. 28)
Spondylocostal dysostoses (SD) is a disorder in which
somitogenesis is disrupted and vertebral segmentation is
affected. Previously, mutations in two genes of theNotch
pathway, DLL3 and MESP2, were linked to SD1 and
SD2, respectively. The Notch signaling pathway is crit-
ical in proper somite formation, and several mousemod-
els that highlight this role have been made. Here, after
recognizing the phenotypic similarities between mice de-
ﬁcient in Dll3 and those lacking a third Notch gene,
Lfng, Sparrow et al. sequence and identify a mutation
in LFNG in a Lebanese family with recessive SD. LFNG
encodes a fucose-speciﬁc b 1,3 N-acetylglucosaminyl-
transferase that posttranslationally modiﬁes the Notch
receptors. The mutation in exon 3 affects a residue con-
served from Drosophila melanogaster to humans and is
hypothesized to interfere with an aromatic ring in the
predicted structure. Although this change does not de-
stabilize the protein, it does render the enzyme inactive
and disrupts the protein’s proper localization to the
Golgi apparatus. Accordingly, a cell-based system dem-
onstrates that Notch signaling is not modulated by mu-
tant Lfng.
Determinants of SMN2 Splicing, by Cartegni et al. (p.
63)
Spinal muscular atrophy (SMA) is an autosomal reces-
sive neurodegenerative disorder caused by mutations in
the SMN1 gene, which encodes the survival motor neu-
ron (SMN) protein. A paralog of SMN1, SMN2, is
nearly identical in sequence but has a T instead of a C
at position 6 of exon 7, leading to an increased level of
exon 7 skipping and the production of an unstable pro-
tein. Researchers hope to learn more about the mech-
anisms regulating this alternative splicing, in an effort
to selectively increase the amount of full-length tran-
script produced by SMN2 in patients lacking functional
SMN1. Previous work has suggested that the splicing
enhancer, SF2/ASF, has enhanced afﬁnity for the se-
quence containing a C at position 6, resulting in the
increased inclusion of exon 7 in SMN1 transcripts. Al-
ternatively, other experiments have demonstrated that it
is actually increased binding of the splicing suppressor,
hnRNP AI, to the SMN2 sequence that leads to the skip-
ping of exon 7. Cartegni et al. reevaluate the situation
with the use of RNA afﬁnity chromatography, in an
effort to remove any experimental bias from the data.
They conclude here that hnRNP A1 binds both se-
quences with equal strength but that SF2/ASF more pref-
erentially binds to the SMN1 sequence. This work pro-
vides new insight into the complex interactions that are
involved in the regulation at splice sites.
D-Bifunctional Protein Deﬁciency, by Ferdinandusse
et al. (p. 112)
D-bifunctional protein (DBP) is a homodimeric enzyme
consisting of a dehydrogenase unit, a hydratase unit, and
a sterol carrier protein 2-like unit. The protein is in-
volved in the oxidation of fatty acids, and patients de-
ﬁcient in DBP are often severely affected with neonatal
hypotonia and seizures. Although most patients with
DBP deﬁciency die before the age of 2 years, there is a
spectrum of phenotype severity, and there are some re-
ported cases in which children survived several years
longer. Ferdinandusse et al. present here a careful in sil-
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ico examination of the structural effects of 61 mutations
and relate them to the severity of the phenotype ob-
served. The deﬁciency can be broken down into three
groups, depending on which DBP unit is affected. The
DBP in type I–deﬁcient patients does not have any de-
hydrogenase or hydratase activity. Type II–deﬁcient pa-
tients lack a functional hydratase unit, and type III–
deﬁcient patients are deﬁcient for dehydrogenase
activity. Whereas type I–deﬁcient patients all have in-
sertions, deletions, or nonsense mutations that affect the
overall structure of DBP, type II and type III mutations
are usually missense mutations that uniquely alter one
subunit of the protein. Changes in the active sites or in
substrate and cofactor binding sites abolish activity,
whereas changes in other sites have less of an effect on
activity. Some mutations speciﬁcally alter the protein
folding of one subunit or the sites of dimerization. From
this collection of data, the authors are able to create a
genotype-phenotype spectrum for DBP mutations that
may be useful in predicting the disease outcome of new
patients with DBP deﬁciency.
This Month on the Cover
In 1866, Gregor Mendel published his observations of
hereditary traits in pea plants. His recognition of the
dominant and recessive nature of variation in seed shape,
seed color, seed coat color, pod shape, pod color, ﬂower
position, and plant height laid the groundwork for mod-
ern genetics.
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